Click Here for 5% Off Your First Aladdin Purchase!

Grapiprant (CJ-023,423) - 98%, high purity , CAS No.415903-37-6, Antagonist of EP 4 receptor

  • Moligand™
  • ≥98%
Item Number
G420030
Grouped product items
SKUSizeAvailabilityPrice Qty
G420030-2mg
2mg
In stock
$42.90
G420030-5mg
5mg
In stock
$88.90
G420030-10mg
10mg
In stock
$147.90
G420030-25mg
25mg
In stock
$246.90
G420030-50mg
50mg
In stock
$444.90
G420030-100mg
100mg
In stock
$801.90
G420030-200mg
200mg
In stock
$1,441.90
View related series
EP4 receptor Antagonist

Basic Description

SynonymsGrapiprant|415903-37-6|CJ-023423|AAT-007|RQ-00000007|N-((4-(2-ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenethyl)carbamoyl)-4-methylbenzenesulfonamide|CJ 023423|CJ-023|CJ-023,423|RQ-7|MR-10A7|UNII-J9F5ZPH7NB|J9F5ZPH7NB|MR10A7|Grapiprant (CJ-023423
Specifications & PurityMoligand™, ≥98%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeANTAGONIST
Mechanism of actionAntagonist of EP 4 receptor
Product Description

Grapiprant (CJ-023,423, AT-001, AAT-007, RQ-00000007, CJ-23423) is a novel selective EP4 Prostaglandin Receptor inhibitor with Ki of 20 nM and 13 nM for rat EP4 receptor and human EP4 receptor, respectively.

Product Properties

ALogP4.6

Associated Targets

HDAC6 Tclin Histone deacetylase 6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGER2 Tclin Prostaglandin E2 receptor EP2 subtype 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGER4 Tclin Prostaglandin E2 receptor EP4 subtype 6 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGER1 Tclin Prostaglandin E2 receptor EP1 subtype 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGFR Tclin Prostaglandin F2-alpha receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGIR Tclin Prostacyclin receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGER3 Tclin Prostaglandin E2 receptor EP3 subtype 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

TBXA2R Tclin Thromboxane A2 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 1-[2-[4-(2-ethyl-4,6-dimethylimidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]-3-(4-methylphenyl)sulfonylurea
INCHI InChI=1S/C26H29N5O3S/c1-5-24-29-25-19(4)28-18(3)16-23(25)31(24)21-10-8-20(9-11-21)14-15-27-26(32)30-35(33,34)22-12-6-17(2)7-13-22/h6-13,16H,5,14-15H2,1-4H3,(H2,27,30,32)
InChi Key HZVLFTCYCLXTGV-UHFFFAOYSA-N
Canonical SMILES CCC1=NC2=C(N1C3=CC=C(C=C3)CCNC(=O)NS(=O)(=O)C4=CC=C(C=C4)C)C=C(N=C2C)C
Isomeric SMILES CCC1=NC2=C(N1C3=CC=C(C=C3)CCNC(=O)NS(=O)(=O)C4=CC=C(C=C4)C)C=C(N=C2C)C
PubChem CID 11677589
Molecular Weight 491.61

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

7 results found

Lot NumberCertificate TypeDateItem
C23081084Certificate of AnalysisNov 23, 2022 G420030
C23081131Certificate of AnalysisNov 23, 2022 G420030
C23081133Certificate of AnalysisNov 23, 2022 G420030
C23081136Certificate of AnalysisNov 23, 2022 G420030
C23081144Certificate of AnalysisNov 23, 2022 G420030
C23081147Certificate of AnalysisNov 23, 2022 G420030
C23081196Certificate of AnalysisNov 23, 2022 G420030

Related Documents

References

1. Nakao K, Murase A, Ohshiro H, Okumura T, Taniguchi K, Murata Y, Masuda M, Kato T, Okumura Y, Takada J.  (2007)  CJ-023,423, a novel, potent and selective prostaglandin EP4 receptor antagonist with antihyperalgesic properties..  J Pharmacol Exp Ther,  322  (2): (686-94).  [PMID:17495127]

Solution Calculators